COMMUNIQUÉS West-GlobeNewswire
-
Ultrahuman and Click Therapeutics partner to launch the world’s first biomarker-driven migraine management tool based on FDA-authorized technology
14/01/2026 -
Omniscient Secures New CPT® Code for Connectomic Analysis, Validating the Clinical Utility of Brain Network Mapping
14/01/2026 -
Cosmos Health Announces Initiation of Analyst Coverage with $4.50 Valuation by Zacks Small-Cap Research
14/01/2026 -
AscellaHealth Launches Strategic Pharmacy Benefits Enablement Platform to Address 2026 Healthcare Cost and Access Challenges
14/01/2026 -
Affidea Suisse acquiert la participation majoritaire dans LabPoint cédée par le groupe Lindenhof, et renforce son offre de diagnostic et de médecine de laboratoire
14/01/2026 -
Affidea acquires a majority stake in LabPoint from Lindenhofgruppe, strengthening its diagnostics and laboratory medicine capabilities
14/01/2026 -
TellDx-Enabled Circulating Tumor Cell Analysis Predicts Response to DLL3-Targeted Therapy in Small Cell Lung Cancer
14/01/2026 -
Eagle Pharmaceuticals Announces Divestiture of Barhemsys
14/01/2026 -
SoldierStrong Announces 2025 Recipients of Annual Individual Commitment to Service Award
14/01/2026 -
HealthTab™ to Expand Across North East London
14/01/2026 -
Acentra Health Appoints Deborah Ricci as Executive Vice President and Chief Financial Officer
14/01/2026 -
Senti Biosciences Participates in Virtual Investor CEO Connect Segment to Discuss the Company’s Groundbreaking AML Data at the American Society of Hematology Annual Meeting and Recently Granted RMAT Designation
14/01/2026 -
Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting
14/01/2026 -
Intuitive Announces Preliminary Fourth Quarter and Full Year 2025 Results
14/01/2026 -
Orion updates time estimate for the potential related to the annual Nubeqa® net sales recorded by Orion
14/01/2026 -
Adial Pharmaceuticals Announces Publication of International PCT Patent Application to Protect Core Assets and Extend IP Exclusivity to at least 2045
14/01/2026 -
Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
14/01/2026 -
Published Peer-Reviewed Study Demonstrates Nexalin’s DIFS™ Neurostimulation Improves Attention and Normalizes Brain Activity in Patients with ADHD
14/01/2026 -
Aeroflow Health and Blue Cross Complete of Michigan Partner to Deliver Essential DME to Medicaid Members
14/01/2026
Pages